1. Introduction Sodium-glucose co-transporter 2 (SGLT2) inhibitors are a class of medications originally used for the treatment of diabetes. SGLT2 inhibitors reduce glucose reabsorption by blocking the SGLT2 receptor in the proximal tubule, thus enhancing glycosuria and improving glycemic control [1,2,3].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Shaul
Contact Shaul, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack